Endocrinology

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

How good are your diagnostic skills? Test them with this month's Visual Dx quiz!

Analysis of the UK Biobank cohort details associations between increased HbA1c levels and risk of myocardial infarction in patients regardless of sex.

An analysis of data from the New Bedford Cohort suggests exposure to endocrine-disrupting chemicals could increased risk of ADHD in adolescents.

The system maintains tight glucose control and reduces the risk of hypoglycemia.

A meta-analysis examines the differences in HbA1c management, weight loss, and other factors associated with long- versus short-acting GLP-1 receptor agonists.

A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age.

A look at nationwide data from an 11-year period gives physicians a greater understanding of predictors, trends, and outcomes associated with stroke in hypertensive disorders of pregnancy.

New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

New analysis suggests use of FRAX score could improve the secondary prevention of fractures in patients with osteoporosis.

Data from the Women's Health Initiative Hormone Therapy trials presented at WCO-IOF-ESCEO 2020 details the reduced risk of fracture seen with hormone therapy in postmenopausal women.

An analysis of female adolescents admitted for anorexia nervosa found the condition could be linked to stunted growth.

A study comparing 22 patients is offering a detailed overview of the effects of weight loss as a result of gastric bypass surgery and diet alone in obese patients.

New research is shedding light on the association between a history of hypertensive disorder of pregnancy and risk of menopausal symptoms later in life.

An analysis of NHANES data suggests those who lost weight between early adulthood and midlife could have drastically reduced their risk of mortality.

An analysis of data from England details the increased odds of mortality associated with type 1 and type 2 diabetes in COVID-19 patients.

A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.

An analysis of 41 individuals with premature adrenarche or polycystic ovary syndrome revealed more than half of the patients were glucocorticoid resistant.

Results of a web-based survey indicate the rate of new type 1 diabetes diagnoses dropped nearly 25% during the early phases of the COVID-19 pandemic.

An analysis of data from the ARIC study is detailing associations between lower levels of sex hormones and risk of incident heart failure in older adults.

New data suggests addition of HbA1c testing could improve youth diabetes screenings in the US compared to current screening standards.

An endocrinologist from New Jersey reflects on whether or not the management of type 2 diabetes should fall under the umbrella of primary care specialists rather than endocrinologists as diabetes become more prevalent.

A systematic review and meta-analysis are diving deeper into the debate over whether metformin should be prescribed to with polycystic ovary syndrome using assisted reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection and embryo transfer.

Results of the VESTA trial indicate fezolinetant could one day provide a non-hormonal, oral option for reducing vasomotor menopausal symptoms and improving quality of life in postmenopausal women.

Having 3 or more pregnancies, a shorter reproductive life span, or early age at menopause onset were linked to increased risk of CAD in a recent study.

Older, white patients and those who use linagliptin are at a higher risk of bullous pemphigoid.

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

An analysis of more than 60k women suggests those with polycystic ovary syndrome were 19% more likely to develop cardiovascular disease.

A practicing endocrinologist and professor of medicine offers insight into the potential for increase in risk of blood clots in certain groups of women if they were to contract COVID-19.